Author:
Ando Hitoshi,Takamura Toshinari,Nagai Yukihiro,Kaneko Shuichi
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860);Asano;Journal of Diabetes and Its Complications,2004
2. Natural progression of diabetic peripheral neuropathy in the zenarestat study population;Brown;Diabetes Care,2004
3. Detection, characterization, and staging of polyneuropathy: Assessed in diabetics;Dyck;Muscle & Nerve,1988
4. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study;Goto;Biomedicine & Pharmacotherapy,1995
5. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group;Greene;Neurology,1999
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献